Therapeutic strategies within the ubiquitin proteasome systemAdam G. Eldridge, Thomas O’Brien(Pfizer (United States))Cell Death and DifferentiationJune 26, 200910.1038/cdd.2009.82Cited by 127SaveCiteExport RISWatch citationsRelated PapersMetabolic Response to NAD Depletion across Cell Lines Is Highly Variable|PLoS ONE|2016|18